Evolv price target raised to $9.50 from $8 at Northland

Northland raised the firm’s price target on Evolv (EVLV) to $9.50 from $8 and keeps an Outperform rating on the shares, citing a “solid” Q2 beat, what it sees as likely strong Q3 bookings, and increased guidance. Following the report, the firm is increasing its FY25 revenue estimate to $133M from $126M, the analyst noted.